OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging drugs for schizophrenia: an update
Luisa-Sophie Köster, Maren Carbon, Christoph U. Correll
Expert Opinion on Emerging Drugs (2014) Vol. 19, Iss. 4, pp. 511-531
Closed Access | Times Cited: 49
Luisa-Sophie Köster, Maren Carbon, Christoph U. Correll
Expert Opinion on Emerging Drugs (2014) Vol. 19, Iss. 4, pp. 511-531
Closed Access | Times Cited: 49
Showing 26-50 of 49 citing articles:
Challenges in the clinical development of non-D2 compounds for schizophrenia
Seth C. Hopkins, Robert Lew, Courtney Zeni, et al.
Current Medical Research and Opinion (2022) Vol. 39, Iss. 3, pp. 467-471
Open Access | Times Cited: 9
Seth C. Hopkins, Robert Lew, Courtney Zeni, et al.
Current Medical Research and Opinion (2022) Vol. 39, Iss. 3, pp. 467-471
Open Access | Times Cited: 9
Paliperidone 3-Month Injection for Treatment of Schizophrenia: A Narrative Review
Amber N. Edinoff, Prithvi Doppalapudi, Claudia Orellana, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 12
Amber N. Edinoff, Prithvi Doppalapudi, Claudia Orellana, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 12
Characterization of six CaMKIIα variants found in patients with schizophrenia
Carolyn N. Brown, Sarah G. Cook, Hillary F. Allen, et al.
iScience (2021) Vol. 24, Iss. 10, pp. 103184-103184
Open Access | Times Cited: 12
Carolyn N. Brown, Sarah G. Cook, Hillary F. Allen, et al.
iScience (2021) Vol. 24, Iss. 10, pp. 103184-103184
Open Access | Times Cited: 12
Elucidating the molecular pharmacology of trace amine‐associated receptor 1 to advance antipsychotic drug discovery
Jingjing Yu, Zheng Xu, Wei Yan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1
Jingjing Yu, Zheng Xu, Wei Yan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1
The preclinical discovery and development of brexpiprazole for the treatment of major depressive disorder
Awais Aftab, Keming Gao
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 10, pp. 1067-1081
Closed Access | Times Cited: 12
Awais Aftab, Keming Gao
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 10, pp. 1067-1081
Closed Access | Times Cited: 12
A quantitative evaluation of traditional health practitioners’ perspectives on mental disorders in KwaZulu-Natal: knowledge, diagnosis, and treatment practices
Ntombifuthi P. Ngubane, Brenda Zola De Gama
Journal of Spirituality in Mental Health (2023) Vol. 26, Iss. 3, pp. 181-201
Closed Access | Times Cited: 3
Ntombifuthi P. Ngubane, Brenda Zola De Gama
Journal of Spirituality in Mental Health (2023) Vol. 26, Iss. 3, pp. 181-201
Closed Access | Times Cited: 3
Electroconvulsive Therapy for Agitation in Schizophrenia: Metaanalysis of Randomized Controlled Trials.
Xiaojing Gu, Wei Zheng, Tong Guo, et al.
PubMed (2017) Vol. 29, Iss. 1, pp. 1-14
Closed Access | Times Cited: 7
Xiaojing Gu, Wei Zheng, Tong Guo, et al.
PubMed (2017) Vol. 29, Iss. 1, pp. 1-14
Closed Access | Times Cited: 7
Discovery of fused heterocyclic carboxamide derivatives as novel α7-nAChR agonists: Synthesis, preliminary SAR and biological evaluation
Yu Xue, Xiaomeng He, Taoyi Yang, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111618-111618
Closed Access | Times Cited: 6
Yu Xue, Xiaomeng He, Taoyi Yang, et al.
European Journal of Medicinal Chemistry (2019) Vol. 182, pp. 111618-111618
Closed Access | Times Cited: 6
Brilaroxazine (RP5063) Clinical Experience in Schizophrenia: "A New Option to Address Unmet Needs"
Laxminarayan Bhat, Marc Cantillon, R. M. J. Ings
Journal of Neurology and Neuromedicine (2018) Vol. 3, Iss. 5, pp. 39-50
Open Access | Times Cited: 6
Laxminarayan Bhat, Marc Cantillon, R. M. J. Ings
Journal of Neurology and Neuromedicine (2018) Vol. 3, Iss. 5, pp. 39-50
Open Access | Times Cited: 6
Evaluation of Brilaroxazine (RP5063) in a Bleomycin-Induced Rodent Model of Idiopathic Pulmonary Fibrosis
Laxminarayan Bhat, Marie-Claude Nault, S.R. Bhat, et al.
Medical Research Archives (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 2
Laxminarayan Bhat, Marie-Claude Nault, S.R. Bhat, et al.
Medical Research Archives (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 2
A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder
Marc Cantillon, R. M. J. Ings, Arul Prakash, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2018) Vol. 43, Iss. 5, pp. 573-585
Open Access | Times Cited: 5
Marc Cantillon, R. M. J. Ings, Arul Prakash, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2018) Vol. 43, Iss. 5, pp. 573-585
Open Access | Times Cited: 5
Antipsychotika
Claudia Mehler‐Wex, Manfred Gerlach, Benno G. Schimmelmann
Springer eBooks (2016), pp. 187-246
Closed Access | Times Cited: 2
Claudia Mehler‐Wex, Manfred Gerlach, Benno G. Schimmelmann
Springer eBooks (2016), pp. 187-246
Closed Access | Times Cited: 2
Managing Schizophrenia: A Challenge for Physicians
Nimra Mumtaz, Muhammad Omair Hassan
(2023), pp. 127-147
Closed Access | Times Cited: 1
Nimra Mumtaz, Muhammad Omair Hassan
(2023), pp. 127-147
Closed Access | Times Cited: 1
Dopamine D 2 Partial Agonists – Discovery, Evolution, and Therapeutic Potential
Marlene A. Jacobson, Wayne E. Childers, Magid Abou‐Gharbia
(2019), pp. 83-130
Closed Access | Times Cited: 2
Marlene A. Jacobson, Wayne E. Childers, Magid Abou‐Gharbia
(2019), pp. 83-130
Closed Access | Times Cited: 2
Omics in schizophrenia: current progress and future directions of antipsychotic treatments
Yidan Sun, Wei Zhou, Luan Chen, et al.
Journal of Bio-X Research (2019) Vol. 02, Iss. 04, pp. 145-152
Open Access | Times Cited: 2
Yidan Sun, Wei Zhou, Luan Chen, et al.
Journal of Bio-X Research (2019) Vol. 02, Iss. 04, pp. 145-152
Open Access | Times Cited: 2
Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D1 Receptor
Tim J. Fyfe, Peter J. Scammells, J. Robert Lane, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3799-3799
Open Access | Times Cited: 2
Tim J. Fyfe, Peter J. Scammells, J. Robert Lane, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3799-3799
Open Access | Times Cited: 2
Antipsychotic Agents
Seth Y. Ablordeppey, Edward Ofori
Burger's Medicinal Chemistry and Drug Discovery (2021), pp. 1-69
Closed Access | Times Cited: 1
Seth Y. Ablordeppey, Edward Ofori
Burger's Medicinal Chemistry and Drug Discovery (2021), pp. 1-69
Closed Access | Times Cited: 1
Desenvolvimento de métodos por cromatografia líquida acoplada à espectrometria de massas em tandem para análises de fármacos (LC-MS/MS no modo column switching com capilar monolítico de sílica híbrida), aminoácidos e neurotransmissores (HILIC-MS/MS) em amostras de plasma de pacientes esquizofrênicos.
Diego Soares Domingues
(2015)
Open Access
Diego Soares Domingues
(2015)
Open Access
Applying the general aggression model in a Taiwanese psychiatric unit: A case study
Pei-Lan Hsu, Mei‐Sang Yang
Journal of Nursing Education and Practice (2016) Vol. 6, Iss. 12
Open Access
Pei-Lan Hsu, Mei‐Sang Yang
Journal of Nursing Education and Practice (2016) Vol. 6, Iss. 12
Open Access
Efeito do nitroprussiato de sódio em voluntários saudáveis e pacientes portadores de esquizofrenia: um estudo de ressonância magnética funcional
Giovana Jorge Garcia
(2016)
Open Access
Giovana Jorge Garcia
(2016)
Open Access
Brilaroxazine (RP5063), a Novel Serotonin-Dopamine Stabilizer, Displays Antipsychotic Efficacy in Rodents
Laxminarayan Bhat, Kouacou Adiey, Seema A. Bhat, et al.
Medical Research Archives (2023) Vol. 11, Iss. 4
Open Access
Laxminarayan Bhat, Kouacou Adiey, Seema A. Bhat, et al.
Medical Research Archives (2023) Vol. 11, Iss. 4
Open Access
Antipsychotika
Claudia Mehler‐Wex, Timo D. Vloet, Manfred Gerlach
Springer eBooks (2023), pp. 235-318
Closed Access
Claudia Mehler‐Wex, Timo D. Vloet, Manfred Gerlach
Springer eBooks (2023), pp. 235-318
Closed Access
Pharmacological Targets and Mechanisms of Action of Antipsychotic Substances in the Context of the Neurochemical Theory of the Pathogenesis of Schizophrenia
Konstantin Y. Kalitin, А. А. Спасов, Olga Y. Mukha, et al.
Neuroscience and Behavioral Physiology (2022) Vol. 52, Iss. 1, pp. 108-123
Closed Access
Konstantin Y. Kalitin, А. А. Спасов, Olga Y. Mukha, et al.
Neuroscience and Behavioral Physiology (2022) Vol. 52, Iss. 1, pp. 108-123
Closed Access
